Page last updated: 2024-08-21

oxazoles and Melanoma

oxazoles has been researched along with Melanoma in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's1 (7.69)18.2507
2000's3 (23.08)29.6817
2010's6 (46.15)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Liu, S; Pan, J; Ye, Q; Zhang, J1
Ameratunga, M; Aspegren, J; Bono, P; Braña, I; de Bono, JS; Korjamo, T; Plummer, R; Postel-Vinay, S; Snapir, A1
Ohshima, Y; Suzuki-Karasaki, M; Suzuki-Karasaki, Y; Takata, N; Tokuhashi, Y; Yoshida, Y1
Aplin, AE; Chervoneva, I; Erkes, DA; Nikbakht, N; Tiago, M1
Aplin, AE; Berger, AC; Capparelli, C; Chervoneva, I; Erkes, DA; Field, CO; Hartsough, EJ; Purwin, TJ; Tiago, M; Villanueva, J1
He, Z; Jordan, R; Kabanov, AV; Luxenhofer, R; Miao, L; S-Manickam, D1
Buijsman, RC; de Man, J; de Roos, JA; de Vetter, JR; Prinsen, MB; Spijkers-Hagelstein, JA; Uitdehaag, JC; van Doornmalen, AM; Zaman, GJ1
Chen, BM; Cheng, CM; Cheng, TL; Liao, KW; Roffler, SR; Tzou, SC1
Al-Abed, Y; Bevelacqua, Y; Cardile, V; Cheng, KF; Dabideen, D; Donia, M; Garotta, G; Harhaji, L; Libra, M; Maksimovic-Ivanic, D; Malaponte, G; Mijatovic, S; Miljkovic, D; Mojic, M; Nicoletti, F; Stosic-Grujicic, S1
Carl, PL; Chakravarty, PK; Katzenellenbogen, JA; Weber, MJ1
Crews, P; Nieto, RM; Rodríguez, J1
Ahn, BZ; Hong, DH; Kim, HM; Kim, Y; Nam, NH; You, YJ1
Hemsworth, GR; Jensen, KE; Kraska, AR; Wolff, JS1

Trials

1 trial(s) available for oxazoles and Melanoma

ArticleYear
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
    British journal of cancer, 2020, Volume: 123, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Biological Availability; Blood Platelets; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms; Oxazoles; Prostatic Neoplasms, Castration-Resistant; Proteins; Pyridines; Quinolines; Sarcoma; Small Cell Lung Carcinoma; Young Adult

2020

Other Studies

12 other study(ies) available for oxazoles and Melanoma

ArticleYear
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.
    Molecular cancer, 2019, 09-16, Volume: 18, Issue:1

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 4; Liver Neoplasms; Male; Melanoma; Mice; Oncogene Addiction; Oxazoles; Signal Transduction; Thiazoles; Transcription Factors; Uveal Neoplasms; Xenograft Model Antitumor Assays

2019
Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
    International journal of oncology, 2017, Volume: 51, Issue:1

    Topics: Acrylamides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoates; Biological Transport; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Membrane Permeability; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Melanoma; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Osteosarcoma; Oxazoles; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured

2017
BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.
    The Journal of investigative dermatology, 2019, Volume: 139, Issue:7

    Topics: Animals; Antineoplastic Agents, Immunological; CD8-Positive T-Lymphocytes; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Forkhead Transcription Factors; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Melanoma; Mice; Nerve Tissue Proteins; Oxazoles; Programmed Cell Death 1 Receptor; Pyridines; Pyrroles; Receptors, Cell Surface; Skin Neoplasms; T-Lymphocytes, Regulatory; Tumor Burden

2019
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.
    Pigment cell & melanoma research, 2019, Volume: 32, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; CD8-Positive T-Lymphocytes; Cell Proliferation; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Oxazoles; Proteins; Pyridines; Pyrroles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.
    Macromolecular bioscience, 2015, Volume: 15, Issue:7

    Topics: Animals; Gene Transfer Techniques; Melanoma; Mice; Oxazoles; Plasmids; Poloxalene; Protein Binding; Transfection; Tumor Cells, Cultured

2015
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Benzimidazoles; beta Catenin; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Indazoles; Indoles; Melanoma; Molecular Targeted Therapy; Mutation; Oxazoles; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Pyridones; Pyrimidinones; Quinolines; Sulfonamides; Triazoles; Vemurafenib

2015
Hapten-directed targeting to single-chain antibody receptors.
    Cancer gene therapy, 2004, Volume: 11, Issue:5

    Topics: Aniline Mustard; Animals; Antibodies, Monoclonal; Cell Line, Tumor; Drug Delivery Systems; Gene Expression; Haptens; Immunotherapy; Injections, Intravenous; Melanoma; Mice; Neoplasms, Experimental; Oxazoles; Polyethylene Glycols; Prodrugs; Receptors, Cell Surface; Recombinant Proteins

2004
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.
    Nitric oxide : biology and chemistry, 2008, Volume: 19, Issue:2

    Topics: Acetates; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Melanoma; Nitric Oxide Donors; Oxazoles; Tumor Suppressor Protein p53; YY1 Transcription Factor

2008
Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
    Journal of medicinal chemistry, 1983, Volume: 26, Issue:5

    Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Cell Transformation, Neoplastic; Female; Fibrinolysin; Isoxazoles; Melanoma; Mice; Nitrogen Mustard Compounds; Oligopeptides; Ovarian Neoplasms; Oxazoles; Plasminogen Activators

1983
New structures and bioactivity patterns of bengazole alkaloids from a choristid marine sponge.
    Journal of natural products, 1993, Volume: 56, Issue:12

    Topics: Alkaloids; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Hydrolysis; Melanoma; Oxazoles; Porifera; Tumor Cells, Cultured

1993
Combretoxazolones: synthesis, cytotoxicity and antitumor activity.
    Bioorganic & medicinal chemistry letters, 2001, Dec-03, Volume: 11, Issue:23

    Topics: Animals; Antineoplastic Agents; Biochemistry; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Melanoma; Mice; Mice, Inbred Strains; Oxazoles; Tumor Cells, Cultured

2001
Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
    Cancer research, 1978, Volume: 38, Issue:4

    Topics: Animals; Carmustine; Doxorubicin; Female; Hypersensitivity, Delayed; Leukemia, Experimental; Leukemia, Lymphoid; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Oxazoles; Oxazolone; Sarcoma 180; Skin

1978